MMA
AVXL icon

Miracle Mile Advisors’s Anavex Life Sciences AVXL Stock Holding History

Miracle Mile Advisors’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-15,492
Closed -$144K – 509
2023
Q4 		$144K Hold
15,492
– – ﹤0.01% 473
2023
Q3 		$101K Hold
15,492
– – ﹤0.01% 468
2023
Q2 		$126K Buy
+15,492
New +$133K ﹤0.01% 490
2023
Q1 		– Sell
-10,547
Closed -$97.7K – 514
2022
Q4 		$97.7K Buy
+10,547
New +$113K ﹤0.01% 495
2021
Q4 		– Sell
-61,656
Closed -$1.11M – 447
2021
Q3 		$1.11M Buy
+61,656
New +$1.23M 0.05% 215

Other funds holding AVXL

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
JAM
Jupiter Asset Management London, United Kingdom $18.8B AUM 29.2% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Rafferty Asset Management
Rafferty Asset Management New York $24.6B AUM 47.06% 1-Year Est. Return
NL
NWAM LLC Mercer Island, Washington $1.74B AUM 32.48% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return